Tuberculosis, commonly known as TB, remains one of the top infectious disease killers worldwide, primarily targeting the lungs. When the bacteria *Mycobacterium tuberculosis* are inhaled, they settle in the alveolar spaces, evading the initial immune response. Understanding how TB affects the lungs is crucial for recognizing symptoms early and seeking appropriate medical intervention.
The Initial Infection and Immune Response
Upon inhalation, the bacilli bypass the mechanical defenses of the upper respiratory tract and reach the lower lungs. Here, they are engulfed by alveolar macrophages, the immune system's first line of defense. However, TB bacteria have evolved a sophisticated mechanism to survive and multiply inside these very cells, essentially hiding from the immune system. This initial phase might be asymptomatic, but it establishes a persistent infection that can remain dormant for years.
Granuloma Formation: The Body's Containment Strategy
To control the infection, the immune system attempts to wall off the bacteria by forming granulomas. These are structured clusters of immune cells that act as containment chambers around the affected area. While this strategy effectively prevents the immediate spread of the bacteria, it also creates a low-oxygen, acidic environment that stresses the bacteria and puts them into a dormant state. This latent TB infection is not contagious but holds the potential to reactivate later.
Progression to Active Pulmonary Tuberculosis
When the immune system is weakened due to factors like HIV, diabetes, malnutrition, or certain medications, the containment can fail. The dormant bacteria can become active again, multiplying rapidly and causing tissue destruction. This progression leads to the classic symptoms of pulmonary TB, including a persistent cough, chest pain, and coughing up sputum or blood. The active disease is contagious and requires immediate treatment to prevent further lung damage.
Impact on Lung Structure and Function
As the infection progresses, the inflammation and bacterial activity cause significant structural changes within the lungs. Cavitation, or the formation of holes in the lung tissue, is a common and serious complication. These cavities impair the lungs' ability to expand and contract efficiently, reducing oxygen exchange. Over time, this can lead to chronic respiratory issues, even after the infection is cured, due to the permanent scarring and loss of lung tissue.
Impaired Gas Exchange: The inflammation and fluid fill the alveoli, preventing oxygen from entering the bloodstream.
Reduced Lung Compliance: Scarring makes the lungs stiffer, requiring more effort to breathe.
Chronic Cough: Persistent irritation and damage to the bronchial tubes lead to prolonged coughing.
Diagnosis and Monitoring of Lung Involvement
Medical professionals utilize a combination of tools to assess how TB is affecting the lungs. A chest X-ray or CT scan is vital for identifying characteristic patterns like infiltrates, cavities, or fibrosis. Sputum smear microscopy and culture confirm the presence of the bacteria, while molecular tests provide rapid detection. These diagnostic methods not only confirm the disease but also help track the progression and effectiveness of treatment over time.
Preventing Further Lung Damage
The most effective way to prevent long-term lung damage from TB is early detection and strict adherence to a full course of antibiotics. Directly Observed Therapy (DOT) is often recommended to ensure patients complete the treatment, which can last for six months or longer. By eliminating the bacteria completely, treatment stops the ongoing inflammatory process that destroys lung tissue, thereby preserving respiratory function and preventing the severe complications associated with advanced TB.
